{
    "organizations": [],
    "uuid": "d91ca3ff67a729d88e5363b52196f14694ce385b",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-obalon-therapeutics-says-audit-com/brief-obalon-therapeutics-says-audit-committees-investigation-into-purported-whistleblower-complaint-concluded-allegations-are-meritless-idUSFWN1QA0FZ",
    "ord_in_thread": 0,
    "title": "BRIEF-Obalon Therapeutics Says Audit Committee's Investigation Into Purported Whistleblower Complaint Concluded Allegations Are Meritless",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 20 (Reuters) - Obalon Therapeutics Inc:\n* OBALON THERAPEUTICS - AUDIT COMMITTEE COMPLETED INVESTIGATION INTO PURPORTED WHISTLEBLOWER COMPLAINT; CONCLUDED ALLEGATIONS ARE MERITLESS\n* OBALON THERAPEUTICS - COMPLAINT RELATED TO SALES PROMOTION DURING Q4 AND ALLEGED THAT REVENUE RELATED TO THE PROMOTION WAS RECOGNIZED IMPROPERLY Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-20T20:28:00.000+02:00",
    "crawled": "2018-02-21T21:32:58.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "obalon",
        "therapeutic",
        "inc",
        "obalon",
        "therapeutic",
        "audit",
        "committee",
        "completed",
        "investigation",
        "purported",
        "whistleblower",
        "complaint",
        "concluded",
        "allegation",
        "meritless",
        "obalon",
        "therapeutic",
        "complaint",
        "related",
        "sale",
        "promotion",
        "q4",
        "alleged",
        "revenue",
        "related",
        "promotion",
        "recognized",
        "improperly",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}